Julphar to extinguish accumulated losses via capital cut

Losses are driven by the suspension of exports to Saudi Arabia, Oman, and Kuwait


Abu Dhabi –  Gulf Pharmaceutical Industries (Julphar) plans to decrease the share capital by AED 503.274 million by canceling a number of the company's shares.

With the capital reduction, Julphar seeks to write off accumulated losses shown in the financial statements for 2019, the company disclosed to the Abu Dhabi Securities Exchange (ADX) on Thursday.

The company's accumulated losses are driven by the suspension of exports to Saudi Arabia, Oman, and Kuwait.

Following the capital cut, the company will issue 500 million new shares at a price of AED 1 per share to increase the capital by a maximum of AED 500 million.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Equities